RX
Live / Applied — Statement of use — non-final action mailed (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 17 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97981293
- Mark type
- Design + words
- Filed
- 17 May 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- Alexis P. Grilli
Goods and services
- Class 035 — Advertising and business services: Pharmaceutical cost management services and drug utilization review services; Business consulting, business management, and business cost analysis of medical diagnosis, medical treatment, pharmaceutical cost management and drug utilization
- Class 044 — Medical, beauty and agricultural services: Telemedicine services; Clinical medical consultation services; Medical and pharmaceutical consultation, advice, and medical analysis services for the diagnosis of conditions and diseases for genomic maladies; Pharmaceutical drug advice; Pharmaceutical drug utilization advice; Health assessment services, namely, providing pharmaceutical drug and, drug utilization for diagnosis and treatment of conditions and diseases for genomic maladies; Genomic benefit management services, namely, medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; managed medical care and pharmaceutical consultation; Providing an Internet website portal featuring medical information in the fields of medicine and pharmaceuticals
Owner
- RxMapper, LLC, Scottsdale, AZ, US
- RxMapper, LLC, Wellesley, MA, US
Prosecution history
- 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 05 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2025 — USE AMENDMENT FILED
- 05 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
- 05 Sept 2025 — DIVISIONAL REQUEST RECEIVED
- 23 Feb 2026 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 23 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Feb 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 18 Jan 2026 — ASSIGNED TO EXAMINER
- 14 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Sept 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED